Selective thrombolysis of central retinal artery occlusion without long- term systemic heparinization

Surgical Neurology

Volumn 50, Issue 5, 1998, Pages 408-410

  Wirostko, William J ^a   Pulido, Jose S ^a   Hendrix, Lloyd E ^b  

^a EYE INSTITUTE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Central retinal artery occlusion; Selective fibrinolysis; Urokinase

Indexed keywords

FIBRINOLYTIC AGENT; HEPARIN; UROKINASE;

AGED; ARTICLE; BLOOD CLOT LYSIS; CASE REPORT; CENTRAL RETINA ARTERY OCCLUSION; HEPARINIZATION; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; LONG TERM CARE; MALE; OPHTHALMIC ARTERY; TREATMENT OUTCOME; VISUAL IMPAIRMENT;

AGED; ANGIOGRAPHY; FIBRINOLYTIC AGENTS; HEPARIN; HUMANS; INFUSIONS, INTRA-ARTERIAL; MALE; OPHTHALMIC ARTERY; RETINAL ARTERY OCCLUSION; THROMBOLYTIC THERAPY; TIME FACTORS; TREATMENT OUTCOME; URINARY PLASMINOGEN ACTIVATOR;

EID: 0032212264     PISSN: 00903019     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-3019(97)00338-8     Document Type: Article

References (6)

1. Brott T., Broderick J., Kothari R. Thrombolytic therapy for stroke. Curr Opin Neurology. 7:1994;25-35.
2. Brown G.C. Retinal arterial obstructive disease. Ryan S.J., Schachat A.P., Murphy R.P. Retina. vol. 2:1994;1361-1377 Mosby, St Louis MO.
3. Kase C.S., O'Neal A.M., Fisher M., Girgis G.N., Ordia J.I. Intracranial hemorrhage after use of tissue plasminogen activator for coronary thrombolysis. Ann Intern Med. 112:1990;17-21.
4. Mames R.N., Shugar J.K., Levy N., Brasington A., Margo C.E. Peripheral thrombolytic therapy for central retinal artery occlusion. Arch Ophthalmol. 113:1995;1094.
5. Margo C.E., Mack W.P. Therapeutic decisions involving disparate clinical outcomes. Ophthalmol. 103:1996;691-696.
6. Schumacher M., Schmidt D., Wakhloo A.K. Intra-arterial fibrinolytic therapy in central retinal artery occlusion. Neuroradiology. 35:1993;600-605.